臨床試驗

Cephea Early Feasibility Study

NCT：NCT05061004 · RECRUITING

NCT IDNCT05061004

狀態RECRUITING

開始日期2022-04-28

完成時間2031-03-01

SponsorAbbott Medical Devices (INDUSTRY)

First posted2021-09-29

Last updated2026-09-11

簡要摘要

The objective of this study is to evaluate the preliminary safety and effectiveness of the Cephea Mitral Valve System for the treatment of symptomatic patients with mitral valve disease (including mitral regurgitation, mitral stenosis and mixed mitral valve disease) in whom transcatheter therapy is deemed more appropriate than open heart surgery.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。